Early research (Phase 1)Study completedNCT01976741What this trial is testingDose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)Who this might be right forNeoplasms Bayer 168
Testing effectiveness (Phase 2)Active Not RecruitingNCT04953104What this trial is testingARID1A and/or KDM6A Mutation and CXCL13 ExpressionWho this might be right forLocally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial Carcinoma+29 more M.D. Anderson Cancer Center 6
Early research (Phase 1)Looking for participantsNCT05614739What this trial is testingFORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3Who this might be right forUrinary Bladder NeoplasmsNeoplasm MetastasisUreteral Neoplasms Eli Lilly and Company 535
Testing effectiveness (Phase 2)Ended earlyNCT04424641What this trial is testingA Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid Tumor(s)Prostate CancerEsophageal Cancer+5 more Genmab 48
Early research (Phase 1)Enrolling By InvitationNCT07218003What this trial is testingA Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4Who this might be right forNon Small Cell Lung CancerCervical CancerHead and Neck Squamous Cell Cancer+7 more Rondo Therapeutics 149
Early research (Phase 1)Study completedNCT03289962What this trial is testingAutogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic TumorsWho this might be right forMelanomaNon-Small Cell Lung CancerBladder Cancer+5 more Genentech, Inc. 273
Early research (Phase 1)Looking for participantsNCT07492628What this trial is testingDual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial CarcinomaWho this might be right forBladder CancerUrothelial CarcinomaMetastatic Urothelial Carcinoma+2 more Beijing Biotech 42
Testing effectiveness (Phase 2)Looking for participantsNCT06031584What this trial is testingBL-M07D1 in Patients With a Variety of Solid Tumors Including Locally Advanced or Metastatic HER2-positive/Low-expressing Urinary and Gastrointestinal TumorsWho this might be right forHer2-positive/Low-expression Urinary and Digestive Tract Tumors Sichuan Baili Pharmaceutical Co., Ltd. 42
Testing effectiveness (Phase 2)WithdrawnNCT06424717What this trial is testingStudy of Avelumab and Tuvusertib in Participants With Advanced Urothelial Cancer That Has Progressed on Prior Anti-PD-(L)1 Therapy (JAVELIN DDRiver Bladder)Who this might be right forUrothelial Carcinoma EMD Serono Research & Development Institute, Inc.
Large-scale testing (Phase 3)UnknownNCT00949455What this trial is testingA Double Blind Randomised Study of Lapatinib and Placebo in Metastatic TCC of the UrotheliumWho this might be right forBladder Cancer Queen Mary University of London 204
Testing effectiveness (Phase 2)Study completedNCT03785925What this trial is testingA Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial CancerWho this might be right forUrinary Bladder NeoplasmNeoplasm Metastasis Nektar Therapeutics 192
Testing effectiveness (Phase 2)Study completedNCT02001623What this trial is testingTisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid TumorsWho this might be right forOvary CancerCervix CancerEndometrium Cancer+5 more Seagen Inc. 195
Large-scale testing (Phase 3)Looking for participantsNCT07129993What this trial is testingStudy of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial CarcinomaWho this might be right forUrothelial CancerBladder Cancer Daiichi Sankyo 630
Testing effectiveness (Phase 2)Ended earlyNCT00089128What this trial is testingGemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder CancerWho this might be right forBladder Cancer Medical University of South Carolina 16
Testing effectiveness (Phase 2)Study completedNCT03628716What this trial is testingCV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder CancerWho this might be right forBladder Cancer Bavarian Nordic 43
Not applicableStudy completedNCT00253708What this trial is testingMassage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic CancerWho this might be right forCancer Beth Israel Deaconess Medical Center 39
Early research (Phase 1)Study completedNCT00648102What this trial is testingPhase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian CancerWho this might be right forBreast CancerColorectal CancerPancreatic Cancer+2 more Celldex Therapeutics 36
Early research (Phase 1)Study completedNCT02443324What this trial is testingRamucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract CancerWho this might be right forGastric AdenocarcinomaAdenocarcinoma of the Gastroesophageal JunctionNon-small Cell Lung Cancer+2 more Eli Lilly and Company 175
Testing effectiveness (Phase 2)Ended earlyNCT03288545What this trial is testingEnfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial CancerWho this might be right forCarcinoma, Transitional CellUrinary Bladder NeoplasmsUrologic Neoplasms+4 more Astellas Pharma Global Development, Inc. 348
Large-scale testing (Phase 3)Study completedNCT02302807What this trial is testingAtezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]Who this might be right forBladder Cancer Hoffmann-La Roche 931